InsidersTradesSigma
Track the DNA X, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). The latest transaction was filed on 10 February 2026 (Attribution). Among the most active insiders: Crolius Clayton. All data is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
DNA X, Inc. is a company listed on the XNAS market. It specializes in developing innovative solutions in the biotechnology sector.